IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $9,483 | -17.5% | 265,330 | -12.8% | 0.08% | -52.7% |
| Q4 2022 | $11,497 | -96.0% | 304,390 | +4643.5% | 0.17% | +4075.0% |
| Q3 2022 | $284,000 | -79.6% | 6,417 | -82.9% | 0.00% | -76.5% |
| Q2 2022 | $1,392,000 | +131.2% | 37,590 | +90.0% | 0.02% | +183.3% |
| Q4 2021 | $602,000 | +119.7% | 19,788 | +142.1% | 0.01% | +50.0% |
| Q3 2021 | $274,000 | -78.2% | 8,173 | -69.2% | 0.00% | -84.0% |
| Q3 2020 | $1,258,000 | +347.7% | 26,507 | +346.7% | 0.02% | +66.7% |
| Q1 2020 | $281,000 | 0.0% | 5,934 | +27.5% | 0.02% | +200.0% |
| Q4 2019 | $281,000 | -94.6% | 4,654 | -92.7% | 0.01% | -98.7% |
| Q1 2019 | $5,156,000 | +1636.0% | 63,522 | +1054.9% | 0.38% | +1728.6% |
| Q4 2018 | $297,000 | – | 5,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |